Lexaria Bioscience: Patented Technology for Rapid Drug Delivery
Lexeria is a leading bioscience company. It began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technolo …
A leading bioscience company with patented technology
Lexeria is a leading bioscience company. It began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technology to an unprecedented degree. Lexaria is a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs. "In many instances, we've reduced the amount of time from 90 or 120 minutes down to as little as five or 10 minutes, " says Chairman & CEO, Chris Bunka.
Lexaria has also demonstrated early-stage effectiveness in improving delivery through human skin. This would be for the potential development of topically-administered products, including patches, creams and lotions.
The company's technology is also currently being evaluated for improved delivery characteristics of antiviral drugs in the fight against COVID-19.
Moreover, Lexaria operates four subsidiary companies to focus on its different commercial opportunities in their respective industries: Lexaria Pharma Corp. investigating new products for hypertension, anti-viral treatments and other drug classes; Lexaria Nicotine Corp. (16.67% owned by Altria Ventures Inc) investigating oral non-combusted tobacco-derived nicotine product formats; Lexaria Hemp Corp. pursuing business-to-business opportunities with cannabinoids such as cannabidiol from hemp; and Lexaria Canpharm Corp. operating a state-of-the-art Health Canada licensed laboratory capable of developing novel psychotropic cannabinoid formulations for potential commercialization in that sector where federally legal to do so. The Lexaria companies sub-license the company’s DehydraTECH technology worldwide for the delivery of fat-soluble active molecules and drugs.
Lexaria expects 2021 to be their busiest year for R & D, with a particular focus on the effective delivery of antiviral drugs and CBD for hypertension.
For more information on Lexaria Bioscience Corp. (NASDAQ: LEXX) please click on the request investor info button.
Latest Articles
Hot Companies
You might also like
Volta Metals: Powering the Future with Ontario’s Critical Minerals
As global demand for critical minerals surges, Volta Metals is strategically positioned in Northwestern Ontario, exploring lithium and rare metals in proximity to infrastructure and clean energy sources.
.png)
.png)
